Medicus Pharma (Medicus Pharma) Cash And Cash Equivalents : $1.72 Mil (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Medicus Pharma Cash And Cash Equivalents?

Medicus Pharma's quarterly cash and cash equivalents increased from Jun. 2023 ($0.15 Mil) to Sep. 2023 ($5.11 Mil) but then stayed the same from Sep. 2023 ($5.11 Mil) to Dec. 2023 ($1.72 Mil).

Medicus Pharma's annual cash and cash equivalents increased from Dec. 2021 ($0.08 Mil) to Dec. 2022 ($0.27 Mil) and increased from Dec. 2022 ($0.27 Mil) to Dec. 2023 ($1.72 Mil).

Medicus Pharma Cash And Cash Equivalents Historical Data

The historical data trend for Medicus Pharma's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicus Pharma Cash And Cash Equivalents Chart

Medicus Pharma Annual Data

Trend

Dec21

Dec22

Dec23

Cash And Cash Equivalents

0.08

0.27

1.72

Medicus Pharma Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash And Cash Equivalents	Get a 7-Day Free Trial				0.27	0.03	0.15	5.11	1.72

Medicus Pharma Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Medicus Pharma (OTCPK:MDPLF) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Medicus Pharma Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Medicus Pharma's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Medicus Pharma (Medicus Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicus Pharma Ltd (OTCPK:MDPLF) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

MDCX:Canada

Address

100 King Street West, Suite 3400, One First Canadian Place, Toronto, ON, CAN, M5X 1A4

Website

http://www.medicuspharma.com

Medicus Pharma Ltd will carry on the business of pharmaceutical drug development focused initially on SkinJect. The objective of SkinJect is developing and commercializing novel microneedle arrays for the purpose of treating certain skin cancers, initially basal cell carcinoma.

Medicus Pharma (Medicus Pharma) Headlines

From GuruFocus

Medicus Pharma Opens the Market

By PRNewswire • 10-26-2023